CLINICAL_TRIALS
trial_result
· 2024-05-29
Clinical Trial Update: Phase 2 Study to Investigate the Efficacy and Safety of Aldoxorubicin in Subjects With Glioblastoma [Phase 2]
Summary
Phase 2 study evaluating the efficacy and safety of Aldoxorubicin in glioblastoma has completed, with results posted in 2024-05-29.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ImmunityBio, Inc. | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2024-05-29